Word

INFINIMMUNE

Status

Pending

Status Code

688

Status Date

Tuesday, June 25, 2024

Serial Number

97827376

Mark Type

4

Filing Date

Tuesday, March 7, 2023

Published for Opposition

Tuesday, April 30, 2024

Trademark Owner History

Infinimmune, Inc. - Owner At Publication

Classifications

9 downloadable computer software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; downloadable computer software in the field of drug design and development

5 pharmaceutical preparations featuring antibodies for medical purposes for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations with protein expression for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes

44 providing medical services and medical information in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing

42 medical research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing and scientific research and development; medical research and development and scientific research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing; pharmaceutical drug development services; providing temporary use of online non-downloadable software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; providing temporary use of online non-downloadable software in the field of drug design and development

Trademark Events

Jul 13, 2023

Teas Change Of Owner Address Received

Mar 10, 2023

New Application Entered

Mar 28, 2023

New Application Office Supplied Data Entered

Jul 13, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 13, 2023

Teas Change Of Correspondence Received

Jul 14, 2023

Teas Voluntary Amendment Received

Jul 14, 2023

Teas Amendment Entered Before Attorney Assigned

Dec 5, 2023

Assigned To Examiner

Dec 29, 2023

Non-Final Action Written

Dec 29, 2023

Non-Final Action E-Mailed

Dec 29, 2023

Notification Of Non-Final Action E-Mailed

Feb 23, 2024

Teas/Email Correspondence Entered

Feb 23, 2024

Correspondence Received In Law Office

Feb 23, 2024

Teas Response To Office Action Received

Mar 25, 2024

Approved For Pub - Principal Register

Apr 10, 2024

Notification Of Notice Of Publication E-Mailed

Apr 30, 2024

Published For Opposition

Apr 30, 2024

Official Gazette Publication Confirmation E-Mailed

Jun 25, 2024

Noa E-Mailed - Sou Required From Applicant